PL2916856T3 - Zastosowania bremelanotydu w leczeniu dysfunkcji seksualnej u kobiet - Google Patents
Zastosowania bremelanotydu w leczeniu dysfunkcji seksualnej u kobietInfo
- Publication number
- PL2916856T3 PL2916856T3 PL13851014T PL13851014T PL2916856T3 PL 2916856 T3 PL2916856 T3 PL 2916856T3 PL 13851014 T PL13851014 T PL 13851014T PL 13851014 T PL13851014 T PL 13851014T PL 2916856 T3 PL2916856 T3 PL 2916856T3
- Authority
- PL
- Poland
- Prior art keywords
- bremelanotide
- treatment
- sexual dysfunction
- female sexual
- female
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261722511P | 2012-11-05 | 2012-11-05 | |
| US201361770535P | 2013-02-28 | 2013-02-28 | |
| PCT/US2013/068386 WO2014071339A2 (en) | 2012-11-05 | 2013-11-05 | Uses of bremelanotide in therapy for female sexual dysfunction |
| EP13851014.4A EP2916856B2 (en) | 2012-11-05 | 2013-11-05 | Uses of bremelanotide in therapy for female sexual dysfunction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL2916856T3 true PL2916856T3 (pl) | 2019-02-28 |
| PL2916856T5 PL2916856T5 (pl) | 2024-01-29 |
Family
ID=50628268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13851014.4T PL2916856T5 (pl) | 2012-11-05 | 2013-11-05 | Zastosowania bremelanotydu w leczeniu dysfunkcji seksualnej u kobiet |
Country Status (23)
| Country | Link |
|---|---|
| US (7) | US9352013B2 (pl) |
| EP (1) | EP2916856B2 (pl) |
| JP (1) | JP6567971B2 (pl) |
| KR (1) | KR102253526B1 (pl) |
| CN (2) | CN104755094A (pl) |
| AU (1) | AU2013337341B2 (pl) |
| BR (1) | BR112015009936A8 (pl) |
| DK (1) | DK2916856T4 (pl) |
| EA (1) | EA032959B9 (pl) |
| ES (1) | ES2701444T5 (pl) |
| FI (1) | FI2916856T4 (pl) |
| GE (2) | GEP20196947B (pl) |
| HK (1) | HK1211227A1 (pl) |
| IL (1) | IL238276B (pl) |
| MX (1) | MX362610B (pl) |
| MY (1) | MY179755A (pl) |
| NZ (1) | NZ707246A (pl) |
| PH (1) | PH12015500915A1 (pl) |
| PL (1) | PL2916856T5 (pl) |
| SG (1) | SG11201502949QA (pl) |
| UA (1) | UA118656C2 (pl) |
| WO (1) | WO2014071339A2 (pl) |
| ZA (1) | ZA201503128B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11590209B2 (en) | 2020-01-21 | 2023-02-28 | Palatin Technologies, Inc. | Use of bremelanotide in patients with controlled hypertension |
| CN119074641A (zh) * | 2024-09-02 | 2024-12-06 | 万邦德制药集团有限公司 | 一种含布雷默浪丹药物组合物、制剂及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7235625B2 (en) * | 1999-06-29 | 2007-06-26 | Palatin Technologies, Inc. | Multiple agent therapy for sexual dysfunction |
| US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| US6579968B1 (en) * | 1999-06-29 | 2003-06-17 | Palatin Technologies, Inc. | Compositions and methods for treatment of sexual dysfunction |
| US7022674B2 (en) | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability |
| JP4943622B2 (ja) * | 2000-05-31 | 2012-05-30 | ノヴォ ノルディスク アー／エス | 使い捨て可能で両端が尖った注射針並びにこの使い捨て可能で両端が尖った注射針を有するインシュリン注射システム |
| AU2002322466B2 (en) | 2001-07-11 | 2007-08-30 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptides |
| WO2006063172A2 (en) * | 2004-12-09 | 2006-06-15 | West Pharmaceutical Services, Inc. | Breech loaded fixed needle syringe and automatic injection device having the same |
| WO2009151714A2 (en) * | 2008-03-24 | 2009-12-17 | Palatin Technologies, Inc. | Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions |
| JP5628796B2 (ja) * | 2008-06-09 | 2014-11-19 | パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. | 性的不能の治療用のメラノコルチンレセプタ特異的ペプチド |
| US9314509B2 (en) * | 2009-11-16 | 2016-04-19 | Ipsen Pharma S.A.S. | Pharmaceutical compositions of melanocortin receptor ligands |
| NZ702172A (en) * | 2010-04-21 | 2016-03-31 | Abbvie Biotechnology Ltd | Wearable automatic injection device for controlled delivery of therapeutic agents |
-
2013
- 2013-11-05 ES ES13851014T patent/ES2701444T5/es active Active
- 2013-11-05 PL PL13851014.4T patent/PL2916856T5/pl unknown
- 2013-11-05 DK DK13851014.4T patent/DK2916856T4/da active
- 2013-11-05 BR BR112015009936A patent/BR112015009936A8/pt not_active Application Discontinuation
- 2013-11-05 AU AU2013337341A patent/AU2013337341B2/en active Active
- 2013-11-05 HK HK15112118.5A patent/HK1211227A1/xx unknown
- 2013-11-05 UA UAA201503523A patent/UA118656C2/uk unknown
- 2013-11-05 NZ NZ707246A patent/NZ707246A/en unknown
- 2013-11-05 GE GEAP201313826A patent/GEP20196947B/en unknown
- 2013-11-05 SG SG11201502949QA patent/SG11201502949QA/en unknown
- 2013-11-05 WO PCT/US2013/068386 patent/WO2014071339A2/en not_active Ceased
- 2013-11-05 KR KR1020157014777A patent/KR102253526B1/ko active Active
- 2013-11-05 CN CN201380056487.9A patent/CN104755094A/zh active Pending
- 2013-11-05 MX MX2015005486A patent/MX362610B/es active IP Right Grant
- 2013-11-05 FI FIEP13851014.4T patent/FI2916856T4/fi active
- 2013-11-05 JP JP2015540853A patent/JP6567971B2/ja active Active
- 2013-11-05 GE GEAP201813826A patent/GEAP201813826A/en unknown
- 2013-11-05 EP EP13851014.4A patent/EP2916856B2/en active Active
- 2013-11-05 CN CN202410025611.5A patent/CN117860866A/zh active Pending
- 2013-11-05 EA EA201590760A patent/EA032959B9/ru not_active IP Right Cessation
- 2013-11-05 MY MYPI2015001016A patent/MY179755A/en unknown
-
2014
- 2014-06-24 US US14/313,258 patent/US9352013B2/en active Active
-
2015
- 2015-04-14 IL IL238276A patent/IL238276B/en active IP Right Grant
- 2015-04-23 PH PH12015500915A patent/PH12015500915A1/en unknown
- 2015-05-05 US US14/704,223 patent/US9700592B2/en active Active
- 2015-05-07 ZA ZA2015/03128A patent/ZA201503128B/en unknown
-
2017
- 2017-07-06 US US15/642,772 patent/US10286034B2/en active Active
-
2019
- 2019-03-28 US US16/368,417 patent/US20190216888A1/en not_active Abandoned
-
2020
- 2020-10-27 US US17/081,732 patent/US20210060120A1/en not_active Abandoned
-
2022
- 2022-07-14 US US17/864,486 patent/US20220362328A1/en not_active Abandoned
-
2024
- 2024-06-13 US US18/742,358 patent/US20240335502A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284423A (en) | Antisense oligonucleotides for the treatment of Pompe disease | |
| IL285843A (en) | Ibrutinib for use in the treatment of chronic graft versus host disease | |
| SG11202012656WA (en) | Heterocyclic compounds useful in the treatment of disease | |
| IL242610A0 (en) | History of pyrazolopyrrolidine and their use in the treatment of diseases | |
| PL3542798T3 (pl) | Aceklidyna do zastosowania w leczeniu starczowzroczności | |
| PL3811943T3 (pl) | Związek do stosowania w leczeniu zaburzeń oczu | |
| SG11201509259RA (en) | Bispecific constructs and their use in the treatment of various diseases | |
| SG11201509012QA (en) | Sobetirome in the treatment of myelination diseases | |
| PL3466425T3 (pl) | Zastosowanie pochodnych glutarimidu w leczeniu chorób eozynofilowych | |
| PT3004108T (pt) | Derivados de pirazolo-pirrolidin-4-ona como inibidores de bet e a sua utilização no tratamento de doenças | |
| PL3004112T3 (pl) | Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby | |
| GB2515440B (en) | Vesicular Formulations for use in the treatment of Rosacea | |
| IL244435A0 (en) | Fidotimide for use in the treatment of diseases associated with inflammation | |
| PL2916856T3 (pl) | Zastosowania bremelanotydu w leczeniu dysfunkcji seksualnej u kobiet | |
| PL3079684T3 (pl) | Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna | |
| HUE036306T2 (hu) | Odiparcil alkalmazása mukopoliszacharidózis kezelésében | |
| ES1074026Y (es) | Dispositivo estimulador del aparato genital masculino y femenino. | |
| AP2015008849A0 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| GB201317518D0 (en) | Versatile sexual stimulation devices | |
| GB201322958D0 (en) | Uses of oligouronates in cancer treatment | |
| CO6970562A2 (es) | Dispositivo y método para ayudar en el tratamiento de córnea | |
| GB201321628D0 (en) | Treatment of disease |